Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library

Discovery of SARS-CoV-2 neutralizing antibodies from a naïve human Ab library

Vimentin could be a major co-factor that aids SARS-CoV-2 infection

Vimentin could be a major co-factor that aids SARS-CoV-2 infection

Proteogenomics can help determine effective treatment for head and neck squamous cell carcinoma

Proteogenomics can help determine effective treatment for head and neck squamous cell carcinoma

Researchers provide comprehensive molecular characterization of head and neck cancers

Researchers provide comprehensive molecular characterization of head and neck cancers

NIAID set to conduct large monoclonal SARS-CoV-2 antibody clinical trial

NIAID set to conduct large monoclonal SARS-CoV-2 antibody clinical trial

UMSOM researchers find greatest risk factors for death in hospitalized COVID-19 patients

UMSOM researchers find greatest risk factors for death in hospitalized COVID-19 patients

Eureka's InvisiMask human antibody nasal spray offers protection against SARS-CoV-2 in mice

Eureka's InvisiMask human antibody nasal spray offers protection against SARS-CoV-2 in mice

New analysis method could pave the way for important breakthroughs in immunotherapy

New analysis method could pave the way for important breakthroughs in immunotherapy

Rapid lateral flow immunoassay enables fluorescence detection of SARS-Cov-2 RNA

Rapid lateral flow immunoassay enables fluorescence detection of SARS-Cov-2 RNA

Osteoporosis drug also promotes infiltration of immune cells in breast tumors

Osteoporosis drug also promotes infiltration of immune cells in breast tumors

MUSC cancer researcher named as a 2020 fellow of National Academy of Innovators

MUSC cancer researcher named as a 2020 fellow of National Academy of Innovators

Researchers analyze outcomes in patients with primary central nervous system lymphoma

Researchers analyze outcomes in patients with primary central nervous system lymphoma

Chemotherapy combined with blinatumomab increases survival for patients with Ph-negative B-ALL

Chemotherapy combined with blinatumomab increases survival for patients with Ph-negative B-ALL

STE90-C11, a SARS-CoV-2 neutralizing antibody, shows high inhibition of RBD-ACE2 binding

STE90-C11, a SARS-CoV-2 neutralizing antibody, shows high inhibition of RBD-ACE2 binding

Secukinumab for treatment of plaque psoriasis in children: Added benefit not proven

Secukinumab for treatment of plaque psoriasis in children: Added benefit not proven

Good cholesterol helps SARS-CoV-2 enter cells

Good cholesterol helps SARS-CoV-2 enter cells

A mutant SARS-CoV-2 subspecies from minks may evade antibody detection

A mutant SARS-CoV-2 subspecies from minks may evade antibody detection

Monoclonal antibody HB27 shows potent neutralizing activity against SARS-CoV-2

Monoclonal antibody HB27 shows potent neutralizing activity against SARS-CoV-2

Inhibiting SARS-CoV-2 cell entry with monoclonal antibodies against staphylococcal enterotoxin B superantigen

Inhibiting SARS-CoV-2 cell entry with monoclonal antibodies against staphylococcal enterotoxin B superantigen

New drug treatment could soon benefit people with rheumatoid arthritis

New drug treatment could soon benefit people with rheumatoid arthritis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.